影响因子:0.333
ISSN:1554-0014
出版社:Mary Ann Liebert, Inc.
出版地:Larchmont, NY
出版国家:United States
刊期:双月刊
创刊时间:2005
语种:英文
审稿周期:偏慢,4-8周
中科院分区:4
投稿命中率:命中率约30.90%容易
国外数据收录:IMIM
中国收录文章数:116
5年影响因子:0.373
研究领域:杂交瘤细胞
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy(formerly Hybridoma), presents the latest developments in characterization and application of mAbs and publishes descriptions and resources of novel mAbs. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy’s targeted coverage advances our understanding of immune responses and is an essential resource on the use of immunological methods for experimental and therapeutic purposes for researchers and clinicians in immunology and cancer biology.
Fully refereed, peer-reviewed articles and short communications present current findings in the development and characterization of mAbs across all therapeutic areas. Development of mAbs for all research applications, including probes, inhibitors, and diagnostic reagents, is also described.
同领域期刊名称 | 影响因子 |